Maximum quantity allowed is 999
请选择数量
CAS RN: | 產品號碼: B6160
BGP-15 Hydrochloride

* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準,敬請留意。
產品號碼 | B6160 |
純度/分析方法 ![]() |
>98.0%(HPLC) |
分子式 / 分子量 | C__1__4H__2__2N__4O__2·xHCl |
外觀與形狀(20°C) | Solid |
儲存條件 ![]() |
Room Temperature (Recommended in a cool and dark place, <15°C) |
儲存在惰性氣體下 | Store under inert gas |
應避免的情況 | Hygroscopic |
相關CAS RN ![]() |
459809-32-6&66611-37-8 |
產品規格
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Melting point | 200.0 to 204.0 °C |
NMR | confirm to structure |
性質
熔點 | 202 °C |
GHS
相關法規
運輸資料
HS編碼* | 2933.39-000 |
Application
BGP-15: A PARP Inhibitor and an Insulin Sensitizer
Poly (ADP-ribose) polymerases (PARPs) is a family of enzymes involved in a number of cellular processes such as DNA repair, genomic stability, and apoptosis.1) BGP-15 has been used in cancer research because of its PARP inhibition.2) In addition, BGP-15 has recently reported as a pharmacological inducer of heat shock protein 72 (HSP72) and a new insulin sensitizer agent candidate.3,4) (The product is for research purpose only.)
References
- 1) Role of PARP Inhibitors in Cancer Biology and Therapy
- 2) Effect of Poly(ADP-Ribose) Polymerase Inhibitors on the Ischemia-Reperfusion-Induced Oxidative Cell Damage and Mitochondrial Metabolism in Langendorff Heart Perfusion System
- 3) HSP72 protects against obesity-induced insulin resistance
- 4) Pharmacological overview of the BGP-15 chemical agent as a new drug candidate for the treatment of symptoms of metabolic syndrome
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。